Knowledge Center
Poster / Nov 12, 2017
Optimizing Disintegration in Tablets of Amorphous Solid Dispersions
Source:
AAPS 2017
Good bioavailability of amorphous solid dispersions (ASDs) not only depends on dissolution rate/extent but also on the capability to inhibit/avoid crystallization, ensuring that supersaturated state is retained to promote absorption. Here, the type and amount of carrier polymer used in ADSs preparation have a strong impact on the rate and extent of precipitation.
Also in the Knowledge Center
/ Dec 28, 2023
Pharmaceutical composition containing sugar and lipid composite particles for inhalation and method for manufacturing same
Read more
Scientific Article
/ Jan 11, 2024
Dry powder inhaler pharmaceutical composition of coated crystalline dry powder for inhalation
Read more
Scientific Article
/ Nov 12, 2024
Webinar - Solving the Insoluble: Webinar on the Science and Application of the Dispersome® Technology
Read more
Scientific Article